Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2. - Ong, Han Wee; Yang, Xuan; Smith, Jeffery L.; Taft-Benz, Sharon; Howell, Stefanie; Dickmander, Rebekah J.; Havener, Tammy M.; Sanders, Marcia K.; Brown, Jason W.; Couñago, Rafael M.; Chang, Edcon; Krämer, Andreas; et al. (Molecules, 2024)